Prognostic value of CD44 splice variants in human stage III cervical cancer
β Scribed by C. Kainz; P. Kohlberger; C. Tempfer; G. Sliutz; G. Gitsch; A. Reinthaller; G. Breitenecker
- Book ID
- 116166466
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 401 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The local expression of CD44 splice variants in human breast cancer tissue has been previously shown to be associated with metastasis. We show here that elevated systemic serum levels of CD44 splice variants occur in breast cancer and may represent a new tool for staging and differential diagnosis.
CD44 is a family of cell surface transmembrane glycoproteins members which differ in the extracellular part by sequences derived by alternative splicing of 10 variant exons (v1-v10). CD44 proteins containing such variant sequences have been implicated in tumor metastasis formation. Here, we have eva
In the present study, the expression and prognostic role of the CD44 splicing variants v5 and v6 were immunohistochemically investigated in 418 curatively resected gastric carcinomas. CD44v5 was expressed in 65β’3 per cent (n=273) and CD44v6 in 77β’0 per cent (n=322) of the tumours. Whereas the expres